These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 25171478

  • 1. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A, Ducena K, Zayakin P, Silina K, Kalnina Z, Sadovska L, Tars J, Vilmanis J, Narbuts Z, Eglitis J, Pirags V, Line A.
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
    Kalniņa Z, Siliņa K, Meistere I, Zayakin P, Rivosh A, Abols A, Leja M, Minenkova O, Schadendorf D, Linē A.
    J Immunol Methods; 2008 May 20; 334(1-2):37-50. PubMed ID: 18314130
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J, Mangé A, Jarlier M, Bascoul-Mollevi C, Rouanet P, Lamy PJ, Maudelonde T, Solassol J.
    Int J Cancer; 2013 Mar 01; 132(5):1105-13. PubMed ID: 22886747
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C, Marchat LA, Herrera L, Díaz-Chávez J, Avante MG, Rodríguez YP, Arreola MC, López-Camarillo C.
    Cancer Biomark; 2020 Mar 01; 27(2):207-211. PubMed ID: 31839604
    [Abstract] [Full Text] [Related]

  • 9. Tumor-associated autoantibody signature for the early detection of gastric cancer.
    Zayakin P, Ancāns G, Siliņa K, Meistere I, Kalniņa Z, Andrejeva D, Endzeliņš E, Ivanova L, Pismennaja A, Ruskule A, Doniņa S, Wex T, Malfertheiner P, Leja M, Linē A.
    Int J Cancer; 2013 Jan 01; 132(1):137-47. PubMed ID: 22684876
    [Abstract] [Full Text] [Related]

  • 10. A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer.
    Shan Q, Lou X, Xiao T, Zhang J, Sun H, Gao Y, Cheng S, Wu L, Xu N, Liu S.
    Cancer Lett; 2013 Jan 01; 328(1):160-7. PubMed ID: 22922091
    [Abstract] [Full Text] [Related]

  • 11. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y, Liao Y, Xiang L, Jiang K, Li S, Huangfu M, Sun S.
    Int J Clin Oncol; 2017 Apr 01; 22(2):291-296. PubMed ID: 27778118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.
    Evans RL, Pottala JV, Nagata S, Egland KA.
    BMC Cancer; 2018 Jan 31; 18(1):119. PubMed ID: 29386014
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 31; 12(2):136-43. PubMed ID: 12582023
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.